Effect of angiotensin blockade and converting enzyme inhibition on renovascular hypertension: comparison between unilateral and bilateral renal artery stenosis. 1987

T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori

The response to angiotensin II analog infusion during sodium deletion and the effects of a one-month captopril treatment were compared between 15 renovascular hypertensive patients with unilateral and 6 with bilateral renal artery stenosis. Plasma renin activity, its response to sodium depletion, and the renal vein renin ratio during sodium depletion were greater in unilateral than in bilateral stenosis. A fall in diastolic blood pressure induced by analog infusion during sodium depletion was correlated with the preinfusion plasma renin activity and with the renal vein renin ratio. Treatment with captopril showed a comparable hypotensive effect in unilateral and bilateral stenosis. The reduction in blood pressure was not correlated with the pretreatment renin levels or changes in blood pressure observed during analog infusion. Plasma renin activity rose and plasma aldosterone level fell in all patients. These results indicate that the mechanism maintaining high blood pressure is more renin dependent in unilateral than in bilateral stenosis and that the long-term effect of captopril does not depend solely on the suppression of the renin-angiotensin-aldosterone system.

UI MeSH Term Description Entries
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
September 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
January 1982, European urology,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
August 1986, Hypertension (Dallas, Tex. : 1979),
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
January 1977, Surgery,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
January 1992, American journal of nephrology,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
January 1984, Lancet (London, England),
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
May 1987, Kidney international. Supplement,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
June 1988, Journal of human hypertension,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
May 1987, Kidney international. Supplement,
T Takabatake, and H Ohta, and Y Yamamoto, and Y Ishida, and H Hara, and Y Ushiogi, and S Nakamura, and N Hattori
March 1978, The New England journal of medicine,
Copied contents to your clipboard!